Immunoassays Market Research Reports & Industry Analysis
An immunoassay is one of the most effectual analytical tests performed due to its specificity, sensitivity and versatility. To test the concentration of a substance within a solution, immunoassay tests use specific antibodies that will react with antigens in the solution. Monoclonal antibodies provide accurate test results and are the most common antibodies used in immunoassay testing due to their ability to bind to one site of any particular molecule. To get an accurate result, the specific antibody must have a high affinity to the antigen being tested for. The number of antigens and antibodies present in the tested solution is measured. This measurement tells how much of the analyte is located within the sample and how concentrated it is.
One of the most widely used immunoassay applications for the detection of infectious disease is the enzyme-linked immunosorbant assay (ELISA). Because of its high sensitivity, the ELISA was the first screening test widely used for HIV.
Immunoassays are significant tests that perform an array of functions in conventional medicine. While it is used primarily to test for things such as HIV in the body, the test can also be used to discover new ways to test for other diseases and conditions that don’t have a direct scientific diagnostic method.
Immunoassays Industry Research & Market Reports
-
Global Protein Assays Market Size study, By Product (Reagents, Kits, Instruments & Accessories), By Technology (Absorbance-based Protein Assays, Colorimetric-based Protein Assays, Fluorescence-based Protein Assays), By Type (Dye-binding Assays, Copper-ion-based Assays, Test Strip-based Assays, Other Protein Assays), By Application (Drug Discovery and Development, Disease Diagnosis, Other Applications), By End User (Pharmaceutical & Biotechnology Companies, Hospitals, Clinical Laboratories, Academic Institutes, Other End Users), and Regional Forecasts 2022-2028
... Assays), By Application (Drug Discovery and Development, Disease Diagnosis, Other Applications), By End User (Pharmaceutical & Biotechnology Companies, Hospitals, Clinical Laboratories, Academic Institutes, Other End Users), and Regional Forecasts 2022-2028 Global Protein Assays Market is ... Read More
-
2022 Clinical Chemistry and Immunodiagnostic POC and Laboratory Instrumentation, and Strategic Profiles of Leading Suppliers
... presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Please ... Read More
-
2022 Microbiology Instrumentation: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Infectious Disease Testing Analyzers and Strategic Profiles of Leading Suppliers
... operating characteristics, features and selling prices. The report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new products ... Read More
-
2022 Emerging Immunodiagnostic Technologies, and Strategic Profiles of Leading Suppliers
... robotics, molecular diagnostics and others. The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products ... Read More
-
2022 Infectious Disease Testing Instrumentation: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Microbiology Analyzers and Strategic Profiles of Leading Suppliers
... characteristics, features and selling prices. The report also presents strategic assessments of leading microbiology market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new products ... Read More
-
2022-2026 Emerging Nucleic Acid Testing (NAT) Assays, Country Market Shares, Strategic Profiles of Leading Reagent and Instrument Suppliers
... emerging NAT assays, as well as extensive listings of companies developing and marketing innovative technologies and products. This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their ... Read More
-
2022-2026 Emerging Immunodiagnostic Tests, Country Market Shares, Strategic Profiles of Leading Reagent and Instrument Suppliers
... Abused Drug assays, including listings of companies developing or marketing new technologies and products. The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market ... Read More
-
2022 France HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals
... volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/ HIV NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood Banks In addition to test ... Read More
-
2022 Germany Hepatitis Molecular and Immunodiagnostics Market: Supplier Shares and Strategies, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals
... on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs Ag, HCV , Anti-HBc , Anti-HBs , Anti-HAV , ... Read More
-
2022 Germany HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals, Physician Offices
... provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV , NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood Banks In addition ... Read More
-
2022 Italy HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals
... volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood Banks In addition to test volume ... Read More
-
2022 UK Hepatitis Molecular and Immunodiagnostics Market: Supplier Shares and Strategies, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals, Public Health Labs
... UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs Ag, HCV , Anti-HBc , ... Read More
-
2022 US HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs
... the US. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood ... Read More
-
2022 France Hepatitis Molecular and Immunodiagnostics Market: Supplier Shares and Strategies, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals
... on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs Ag, HCV , Anti-HBc , Anti-HBs , Anti-HAV , ... Read More
-
2022 Italy Hepatitis Molecular and Immunodiagnostics Market: Supplier Shares and Strategies, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals
... on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs Ag, HCV , Anti-HBc , Anti-HBs , Anti-HAV , ... Read More
-
2022 USA Hepatitis Molecular and Immunodiagnostics Market: Supplier Shares and Strategies, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs
... in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs Ag, HCV , ... Read More
-
2022 Global HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs
... in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. For each country, the report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/ NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in ... Read More
-
2022 UK HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals
... test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/ HIV NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood Banks - Physician Offices ... Read More
-
Diagnostic Specialty Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB, Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria, Hepatitis, HIV, E. coli , Tuberculosis, Pneumonia, Cancer)- Forecast to 2029
... Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB, Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria, Hepatitis, HIV, E. coli , Tuberculosis, Pneumonia, Cancer)- Forecast to 2029 The diagnostic specialty antibodies ... Read More
-
2022 Global Forecast for Veterinary Rapid Test (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
ATP Assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) - Global Forecast to 2027
... projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%. The growth of this market can largely be attributed to the increasing food safety concerns, growing ... Read More
-
Biodefense Market Size By Product (Vaccines {Anthrax, Smallpox, Botulism}, Biothreat Detection Devices {Samplers, Detectors/Triggering Devices, Identifiers, Assays and Reagents}), Industry Analysis Report, Regional Outlook, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022- 2028
... 2028 The biodefense market is anticipated to grow substantially by 2028 on account of increasing government initiatives for promoting treatment strategies to develop effective vaccines to combat mutated vaccines as well as detection devices against ... Read More
-
2022-2026 France Hepatitis Diagnostic Testing Market: Supplier Shares, Volume and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Assays, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers
... the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs ... Read More
-
2022-2026 US Hepatitis Diagnostic Testing Market: Supplier Shares, Volume and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Tests, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers
... the Hepatitis diagnostics market in US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs ... Read More
-
2022-2026 Italy Hepatitis Diagnostic Testing Market: Supplier Shares, Volume and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Tests, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers
... the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs ... Read More
Research Assistance
